AI-driven regulatory insights are transforming pharmacovigilance by enabling real-time monitoring, improving compliance, reducing risk, and streamlining decision-making across global drug safety operations.

Machine learning streamlines local literature reviews, enhancing pharmacovigilance compliance by automating detection of adverse drug reactions, ensuring faster, more accurate, and efficient safety monitoring.